AMANDA SIEVE: Open Payments
NPI 1972098150 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 14 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $287 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Neos Therapeutics, LP | 2 | $36 |
| Lilly USA, LLC | 1 | $27 |
| Biogen, Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: Auvelity, CAPLYTA, Adzenys XR-ODT, MOUNJARO, ZURZUVAE, REXULTI, Quviviq, FANAPT.
Industry payments across IA — which companies pay providers there.
